These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11267024)

  • 1. Immunosuppression of direct T-cell-mediated xenorecognition in vitro.
    Rogers NJ; Mirenda V; Jackson I; Dorling A; Lechler RI
    Transplant Proc; 2001; 33(1-2):697-8. PubMed ID: 11267024
    [No Abstract]   [Full Text] [Related]  

  • 2. Transplantation and the CD28/CTLA4/B7 pathway.
    Alegre M; Fallarino F; Zhou P; Frauwirth K; Thistlethwaite J; Newell K; Gajewski T; Bluestone J
    Transplant Proc; 2001; 33(1-2):209-11. PubMed ID: 11266782
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of the B7-CD28/CTLA-4 pathway in autoimmune disease.
    Chang TT; Kuchroo VK; Sharpe AH
    Curr Dir Autoimmun; 2002; 5():113-30. PubMed ID: 11826754
    [No Abstract]   [Full Text] [Related]  

  • 4. Costimulatory regulation of T cell function.
    Chambers CA; Allison JP
    Curr Opin Cell Biol; 1999 Apr; 11(2):203-10. PubMed ID: 10209159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation.
    Vandenborre K; Van Gool SW; Kasran A; Ceuppens JL; Boogaerts MA; Vandenberghe P
    Immunology; 1999 Nov; 98(3):413-21. PubMed ID: 10583602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New protein steals the show as 'costimulator' of T cells.
    Cohen J
    Science; 1993 Nov; 262(5135):844-5. PubMed ID: 7694360
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of human anti-pig T cell response by anti-CD2, anti-CD40L, and CTLA4-Ig: a comparative study.
    Xu Y; Ryan D; Wu C; Bazin H; Latinne D; White-Scharf ME; Thall AD
    Transplant Proc; 2000 Aug; 32(5):926. PubMed ID: 10936275
    [No Abstract]   [Full Text] [Related]  

  • 8. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation.
    Dahlén E; Hedlund G; Dawe K
    J Immunol; 2000 Mar; 164(5):2444-56. PubMed ID: 10679081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression.
    Carreno BM; Bennett F; Chau TA; Ling V; Luxenberg D; Jussif J; Baroja ML; Madrenas J
    J Immunol; 2000 Aug; 165(3):1352-6. PubMed ID: 10903737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4.
    Mandelbrot DA; Oosterwegel MA; Shimizu K; Yamada A; Freeman GJ; Mitchell RN; Sayegh MH; Sharpe AH
    J Clin Invest; 2001 Apr; 107(7):881-7. PubMed ID: 11285307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell stimulation: an abundance of B7s.
    Abbas AK; Sharpe AH
    Nat Med; 1999 Dec; 5(12):1345-6. PubMed ID: 10581066
    [No Abstract]   [Full Text] [Related]  

  • 12. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.
    Broeren CP; Gray GS; Carreno BM; June CH
    J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
    Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
    J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD28/CTLA-4 and CD80/CD86 families: signaling and function.
    Slavik JM; Hutchcroft JE; Bierer BE
    Immunol Res; 1999; 19(1):1-24. PubMed ID: 10374692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
    Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
    J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An engineered bifunctional recombinant molecule that regulates humoral and cellular effector functions of the immune system.
    Pizzolato MC; Fodor WL
    Transplantation; 2003 Feb; 75(4):542-9. PubMed ID: 12605124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinogen-modified dendritic cells induce immunosuppression by incomplete T-cell activation resulting from impaired antigen uptake and reduced CD86 expression.
    Woods GM; Doherty KV; Malley RC; Rist MJ; Muller HK
    Immunology; 2000 Jan; 99(1):16-22. PubMed ID: 10651936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD28-independent costimulation of T cells in alloimmune responses.
    Yamada A; Kishimoto K; Dong VM; Sho M; Salama AD; Anosova NG; Benichou G; Mandelbrot DA; Sharpe AH; Turka LA; Auchincloss H; Sayegh MH
    J Immunol; 2001 Jul; 167(1):140-6. PubMed ID: 11418642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoinhibitory DNA vaccine protects against autoimmune diabetes through cDNA encoding a selective CTLA-4 (CD152) ligand.
    Prud'homme GJ; Chang Y; Li X
    Hum Gene Ther; 2002 Feb; 13(3):395-406. PubMed ID: 11860706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of autoimmunity by inhibition of T cell costimulation.
    Daikh DI; Wofsy D
    Adv Exp Med Biol; 2001; 490():113-7. PubMed ID: 11505969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.